The latest thoracic oncology news
Targeted cancer drugs are widely used because of their ability to inhibit specific proteins involved…
On October 11, 2023, the Food and Drug Administration approved encorafenib with binimetinib for adult patients with…
Results from the randomised Phase 3 clinical trial (Atalante-1) on T-cell epitope cancer vaccine in HLA-A2…
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine found that…
Small cell lung cancer accounts for about 15 percent of all diagnosed lung cancers and…
Secondary analysis results from the phase III NRG Oncology-RTOG 0617 clinical trial comparing standard- versus…
Osimertinib plus chemotherapy demonstrated a statistically significant and clinically meaningful progression-free survival benefit compared to…
The Taiwan National Lung Cancer Early Detection Program detected 85 percent of lung cancer cases…
A study presented at the International Association for the Study of Lung Cancer 2023 World…
There’s been a striking 79% increase in new cases of cancer among the under 50s…